Searched for
PHARMA FUND
NFO Alert: Invesco Mutual Fund announces launch of pharma and healthcare fundInvesco Mutual Fund has launched a new open-ended equity scheme. This fund will invest in India's evolving pharma and healthcare sectors. I...- Strong earnings propel mid- and small-cap stocks to a significant rally on D-StMid and small-cap firms achieved their sharpest revenue growth in sixteen quarters. Aggregate revenue climbed twenty percent, and operating...
- End dependence days: What India should and should not buildCurrent government procurement policies can obstruct innovation, often favouring established firms. Furthermore, major Indian corporations ...
- FIIs dumped nearly Rs 1 lakh crore worth of these 10 stocks but 8 defied the selloffForeign investors sold nearly Rs 1 lakh crore from ten Indian stocks. Eight of these companies saw their stock prices increase despite the ...
- Quant Mid Cap Fund exits Anthem Biosciences and Lenskart Solutions, adds Cochin Shipyard and 4 others in JulyQuant Mid Cap Fund exited Anthem Biosciences and Lenskart Solutions in July, while adding five new stocks including Cochin Shipyard, UPL an...
- Mutual funds raise IT exposure to 6.6% in July after record low. Is sentiment towards tech improving?In July, mutual funds increased their allocation to the IT sector to 6.6 per cent, marking a positive shift after an extended period of min...
- Top FPIs ride out storm, outrun Nifty & Sensex in Q1During the June quarter, leading international funds encountered remarkable gains within Indian equities, significantly boosting their repo...
- INDO-MIM, Ather Energy and TCS among stocks bought and sold by mutual funds in JulyMutual funds bought Rs 15,900 crore of stocks in July while FIIs sold Rs 11,000 crore. Axis Bank, INDO-MIM and Kotak Mahindra Bank saw majo...
- How investors can use thematic funds to boost portfolio returnsThematic funds focus on investing in firms associated with particular long-term trends, aiming for potential alpha returns. They entail a g...
- Warburg set to buy Seacod-maker Universal NutriScience for Rs 2800 croreWill be 4th acquisition for the US private equity giant in India’s healthsector in four months. Kedaara to make 5x rupee returns on exit.
- World Bank's IFC, HDFC AMC invest in Molbio Diagnostics' Rs 281 crore IPO anchor roundMolbio Diagnostics raised Rs 281 crore from anchor investors, including World Bank Group's IFC and HDFC Mutual Fund, ahead of its Rs 940 cr...
- Sensex down nearly 8% in 2026. Best time to top up your mutual fund SIPs?The BSE Sensex has declined nearly eight percent, prompting investors to consider increasing mutual fund SIP contributions. Market experts ...
- These large and mid-cap stocks can give more than 20% return in 1 year, according to analystsWhenever there is a correction or volatility, just ask one question: Is it an opportunity, or should one be wary? We are raising this issue...
- Time to increase the risk quotient? Maybe, but selectively: 5 largecaps from different sectors with upside potential of up to 30%When a market starts rising and buying makes a comeback, something happens to a large majority of investors. They get restless. The safe, m...
- India Inc goes on a global shopping spree with a new wishlistIndian companies are increasingly pursuing strategic overseas acquisitions. They now focus on acquiring capabilities and technology rather ...
- ETMarkets NRI Talk | Alternatives can account for up to 20% of an NRI's India allocation: Shiv GuptaFrom portfolio management services (PMS) and alternative investment funds (AIFs) to private credit, these asset classes offer the potential...
- 9 microcap multibaggers: How India's stock market minnows beat every major index in six monthsIndia's smallest listed stocks delivered the strongest market run in six months. The Nifty Microcap 250 index rose eleven percent, beating ...
- AI trade unwind, FII inflows brighten August outlook for Indian stocksIndian equities are expected to extend recent gains in August, supported by foreign fund inflows. Analysts anticipate a continued upward mo...
- Piramal Pharma to focus on policy, not Trump tariff tweets: Nandini PiramalPiramal Pharma will focus on policy actions amid tariff concerns. Its global manufacturing network offers a significant advantage. The comp...
- Pharma mutual funds top return charts across horizons. Should investors chase the rally or stay cautious?Pharma mutual funds are leading returns in CY2026, driven by strong earnings, defensive demand, and US export growth. Despite recent outper...
Load More
